The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV 1 receptors but not cannabinoid receptors in rat joints

British Journal of Pharmacology

Volumn 142, Issue 8, 2004, Pages 1361-1367

  Baker, Chris L ^a   McDougall, Jason J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

ACEA; Blood flow; Cannabinoid; Capsaicin; Capsazepine; Knee joint; Neurogenic inflammation; Sensory nerves; Vanilloid receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ARACHIDONYL 2 CHLOROETHYLAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; CAPSAZEPINE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; KNEE; MALE; MYELINATED NERVE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; VASODILATATION; VASOMOTOR REFLEX;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ION CHANNELS; KNEE JOINT; MALE; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; TRPV CATION CHANNELS;

EID: 4444247073     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705902     Document Type: Article

References (44)

1. BARIN, A.K. & MCDOUGALL, J.J. (2003). Endomorphin-1 causes synovial hypoaemia in rat knee joints via a capsaicin-sensitive neural pathway. Neurosci. Lett., 344, 21-24.
2. BELTRAMO, M., STELLA, N., CALIGNANO, A., LIN, S.Y., MAKRIYANNIS, A. & PIOMELLI, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
3. CALIGNANO, A., LA RANA, G., BELTRAMO, M., MAKRIYANNIS, A. & PIOMELLI, D. (1997). Potentiation of anandamide hypotension by the transport inhibitor, AM404. Eur. J. Pharmacol., 337, R1-R2.
4. DEUTSCH. D.G. & CHIN, S.A. (1993). Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791-796.
5. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
6. DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372, 686-691.
7. ELLIS, E.F., MOORE, S.F. & WILLOUGHBY, K.A. (1995). Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol., 269, H1859-H1864.
8. FARQUHAR-SMITH, W.P., EGERTOVA, M., BRADBURY, E.J., MCMAHON, S.B., RICE, A.S. & ELPHICK, M.R. (2000). Cannabinoid CB(1) receptor expression in rat spinal cord. Mol. Cell. Neurosci., 15, 510-521.
9. FELDER, C.C., NIELSEN, A., BRILEY, E.M., PALKOVITS, M., PRILLER, J., AXELROD, J., NGUYEN, D.N., RICHARDSON, J.M., RIGGIN, R.M., KOPPEL, G.A., PAUL, S.M. & BECKER, G.W. (1996). Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett., 393, 231-235.
10. FERRELL, W.R., LAM, F. & MONTGOMERY, I. (1992). Differences in the axon composition of nerves supplying the rat knee joint following intra-articular injection of capsaicin. Neurosci. Lett., 141, 259-261.
11. FERRELL, W.R., MCDOUGALL, J.J. & BRAY, R.C. (1997). Spatial heterogeneity in the effects of calcitonin gene-related peptide (CGRP) on the microvasculature of ligaments in the rabbit knee joint. Br. J. Pharmacol., 121, 1397-1405.
12. FORD, W.R., HONAN, S.A., WHITE, R. & HILEY, C.R. (2002). Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br. J. Pharmacol., 135, 1191-1198.
13. FOWLER, C.J. & JACOBSSON, S.O. (2002). Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide - targets for drug development? Prostaglandins Leukot. Essent. Fatty Acids, 66, 193-200.
14. GARCIA, N., JR, JARAI, Z., MIRSHAHI, F., KUNOS, G. & SANYAL, A.J. (2001). Systemic and portal hemodynamic effects of anandamide. Am. J. Physiol., 280, G14-G20.
15. GAULDIE, S.D., MCQUEEN, D.S., PERTWEE, R. & CHESSELL, I.P. (2001). Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br. J. Pharmacol., 132, 617-621.
16. GRIFFIN, G., FERNANDO, S.R., ROSS, R.A., MCKAY, N.G., ASHFORD, M.L., SHIRE, D., HUFFMAN, J.W., YU, S., LAINTON, J.A. & PERTWEE, R.G. (1997). Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol., 339, 53-61.
17. HILLARD, C.J., MANNA, S., GREENBERG, M.J., DICAMELLI, R., ROSS, R.A., STEVENSON, L.A., MURPHY, V., PERTWEE, R.G. & CAMPBELL, W.B. (1999). Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Therap., 289, 1427-1433.
18. HÖGESTATT, E.D. & ZYGMUNT, P.M. (2002). Cardiovascular pharmacology of anandamide. Prostaglandins Leukot. Essent. Fatty Acids, 66, 343-351.
19. JARAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.I., BUCKLEY, N.B., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 14136-14141.
20. KARIMIAN, S.M., MCDOUGALL, J.J. & FERRELL, W.R. (1995). Neuropepitidergic and autonomic control of the vasculature of the rat knee joint revealed by laser Doppler perfusion imaging. Exp. Physiol., 80, 341-348.
21. LAY, L., ANGUS, J.A. & WRIGHT, C.E. (2000). Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Eur. J. Pharmacol., 391, 151-161.
22. LUK, W.S. & LAM, F. Y. (2004). Does the vanilloid receptor (VR1) mediate anandamide-induced vasodilatation in the rat knee joint?. In: XIV European Neuropeptide Club Meeting, eds. BELMONTE, C. & ARACIL, A. Spain: Alicante.
23. MALINOWSKA, B., GODLEWSKI, G., BUCHER, B. & SCHLICKER, E. (1997). Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn-Schimedeberg's Arch. Pharmacol., 356, 197-202.
24. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
25. MCDOUGALL, J.J. (2003). Involvement of sympathetic efferents but not capsaicin-sensitive afferents in nociceptin-mediated dual control of rat synovial blood flow. Am. J. Physiol., 284, R1477-R1485.
26. MCDOUGALL, J.J., FERRELL, W.R. & BRAY, R.C. (1997). Spatial variation in sympathetic influences on the vasculature of the synovium and medial collateral ligament of the rabbit knee joint. J. Physiol., 503, 435-443.
27. MCDOUGALL, J.J., KARIMIAN, S.M. & FERRELL, W.R. (1994). Alteration of substance P-mediated vasodilatation and sympathetic vasoconstriction in the rat knee joint by adjuvant-induced inflammation. Neurosci. Lett., 174, 127-129.
28. MCDOUGALL, J.J., KARIMIAN, S.M. & FERRELL, W.R. (1995). Prolonged alteration of sympathetic vasoconstrictor and peptidergic vasodilator responses in rat knee joints by adjuvant-induced arthritis. Exp. Physiol., 80, 349-357.
29. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
30. PERTWEE, R.G. (2001). Cannabinoid receptors and pain. Progr. Neurobiol., 63, 569-611.
31. PERTWEE, R.G. (1999). Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem., 6, 635-664.
32. RALEVIC, V., KENDALL, D.A., RANDALL, M.D., ZYGMUNT, P.M., MOVAHED, P. & HOGESTATT, E.D. (2000). Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries. Br. J. Pharmacol., 130, 1483-1488.
33. RANDALL, M.D., ALEXANDER, S.P., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 229, 114-120.
34. RICE, S.C., FARQUHAR-SMITH, W.P., BRIDGES, D. & BROOKS, J.W. (2003). Cannabinoids and pain. In: Proceedings of the 10th World Congress on Pain, ed. Dostrovsky, J.O., Carr, D.B. & Koltzenburg, M. pp. 437-468. Seattle: IASP Press.
35. SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227-230.
36. SMITH, P.J. & MCQUEEN, D.S. (2001). Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat. Br. J. Pharmacol., 134, 655-663.
37. TSOU, K., BROWN, S., SANUDO-PENA, M.C., MACKIE, K. & WALKER, J.M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
38. VARGA, K., LAKE, K., MARTIN, B.R. & KUNOS, G. (1995). Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279-283.
39. VARGA, K., LAKE, K.D., HUANGFU, D., GUYENET, P.G. & KUNOS, G. (1996). Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension, 28, 682-686.
40. VIDRIO, H., SANCHEZ-SALVATORI, M.A. & MEDINA, M. (1996). Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats. J. Cardiovasc. Pharmacol., 28, 332-336.
41. WAGNER, J.A., JARAI, Z., BATKAI, S. & KUNOS, G. (2001). Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur. J. Pharmacol., 423, 203-210.
42. WHITE, R. & HILEY, C.R. (1998). The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery. Br. J. Pharmacol., 125, 533-541.
43. ZHANG, J., HOFFERT, C., VU, H.K., GROBLEWSKI, T., AHMAD, S. & O'DONNELL, D. (2003). Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci., 17, 2750-2754.
44. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.